Physician profile
Justin E Chronister
NPI 1073772950
$9,187.72
in general payments reported to CMS, 2019-2025
27 companies · $518 in 2025
The $518 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $832 · 2021: $2,511 · 2022: $2,544 · 2023: $1,030 · 2024: $916 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,464.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,728.78 | 2019-2025 | Mako, Triathlon |
| Pacira Therapeutics, INC. | $212.38 | 2019-2021 | |
| Osteocentric Technologies, INC. | $179.00 | 2019 | |
| Ermi LLC | $143.33 | 2020-2025 | |
| Horizon Therapeutics Plc | $129.37 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $76.86 | 2021 | |
| Medacta USA, INC. | $66.74 | 2022-2023 | Reverse Shoulder, Gmk Sphere |
| Catalyst Orthoscience | $58.02 | 2022 | |
| Globus Medical, INC. | $56.91 | 2022-2024 | Ankle Fracture System |
| Innovation Technologies INC | $55.30 | 2022 | |
| Medinc of Texas | $54.29 | 2024 | |
| Depuy Synthes Sales INC. | $42.26 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $41.03 | 2022-2023 | Seglentis |
| Ethicon US, LLC | $39.24 | 2022-2024 | Ethicon, Vistaseal, Dermabond |
| Curonix LLC | $36.41 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $35.22 | 2021 | |
| Bioventus LLC | $32.58 | 2022 | |
| Alafair Biosciences, INC. | $26.99 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $26.37 | 2025 | |
| Medtronic, INC. | $21.30 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.64 | 2025 | Zilretta |
| Intellijoint Surgical INC. | $19.54 | 2019 | |
| Abbott Laboratories | $18.65 | 2025 | Eterna |
| Baudax Bio INC. | $17.97 | 2020 | |
| Ferring Pharmaceuticals INC. | $17.17 | 2019 | |
| Wright Medical Technology, INC. | $17.00 | 2019 | |
| Biom'Up France Sas | $14.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Chronister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.